{"product_id":"tirzepatide-40-mg-retatrutide-20-mg","title":"TIRZEPATIDE 40 MG \/ RETATRUTIDE 20 MG","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\" data-end=\"106\" data-start=\"0\"\u003e\u003cstrong data-end=\"43\" data-start=\"2\"\u003eTirzepatide 40 mg \/ Retatrutide 20 mg\u003c\/strong\u003e blend combines two incretin-based peptides in a \u003cstrong data-end=\"105\" data-start=\"92\"\u003e2:1 ratio\u003c\/strong\u003e:\u003cspan class=\"PDq2pG_selectionAnchor\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-end=\"617\" data-start=\"108\"\u003e\n\u003cli data-end=\"267\" data-start=\"108\" data-section-id=\"jfb4k9\"\u003e\n\u003cstrong data-end=\"125\" data-start=\"110\"\u003eTirzepatide\u003c\/strong\u003e – a \u003cstrong data-end=\"165\" data-start=\"130\"\u003edual GIP\/GLP-1 receptor agonist\u003c\/strong\u003e that is FDA-approved for type 2 diabetes and obesity under brand names such as Mounjaro and Zepbound.\u003c\/li\u003e\n\u003cli data-end=\"617\" data-start=\"268\" data-section-id=\"1fsea31\"\u003e\n\u003cstrong data-end=\"285\" data-start=\"270\"\u003eRetatrutide\u003c\/strong\u003e – an \u003cstrong data-end=\"325\" data-start=\"291\"\u003einvestigational triple agonist\u003c\/strong\u003e that activates \u003cstrong data-end=\"379\" data-start=\"341\"\u003eGLP-1, GIP, and glucagon receptors\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"645\" data-start=\"619\" data-section-id=\"1vcbnde\"\u003eWhat is it studied for?\u003c\/h2\u003e\n\u003ch3 data-end=\"866\" data-start=\"851\" data-section-id=\"hqee7v\"\u003eTirzepatide\u003c\/h3\u003e\n\u003cp data-end=\"908\" data-start=\"867\"\u003eResearchers have studied tirzepatide for:\u003c\/p\u003e\n\u003cul data-end=\"1085\" data-start=\"909\"\u003e\n\u003cli data-end=\"934\" data-start=\"909\" data-section-id=\"gp20n3\"\u003eWeight loss and obesity\u003c\/li\u003e\n\u003cli data-end=\"952\" data-start=\"935\" data-section-id=\"1ubisqz\"\u003eType 2 diabetes\u003c\/li\u003e\n\u003cli data-end=\"974\" data-start=\"953\" data-section-id=\"rzotnb\"\u003eBlood sugar control\u003c\/li\u003e\n\u003cli data-end=\"999\" data-start=\"975\" data-section-id=\"10vau9c\"\u003eCardiometabolic health\u003c\/li\u003e\n\u003cli data-end=\"1044\" data-start=\"1000\" data-section-id=\"8v0v6f\"\u003eObstructive sleep apnea related to obesity\u003c\/li\u003e\n\u003cli data-end=\"1085\" data-start=\"1045\" data-section-id=\"1psx5in\"\u003eFatty liver disease (ongoing research)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"1102\" data-start=\"1087\" data-section-id=\"104cz63\"\u003eRetatrutide\u003c\/h3\u003e\n\u003cp data-end=\"1144\" data-start=\"1103\"\u003eResearchers are studying retatrutide for:\u003c\/p\u003e\n\u003cul data-end=\"1344\" data-start=\"1145\"\u003e\n\u003cli data-end=\"1154\" data-start=\"1145\" data-section-id=\"1sdi1jr\"\u003eObesity\u003c\/li\u003e\n\u003cli data-end=\"1172\" data-start=\"1155\" data-section-id=\"1ubisqz\"\u003eType 2 diabetes\u003c\/li\u003e\n\u003cli data-end=\"1239\" data-start=\"1173\" data-section-id=\"h0ulqv\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD)\u003c\/li\u003e\n\u003cli data-end=\"1265\" data-start=\"1240\" data-section-id=\"1qek3ks\"\u003eObstructive sleep apnea\u003c\/li\u003e\n\u003cli data-end=\"1311\" data-start=\"1266\" data-section-id=\"ky8mt4\"\u003eKnee osteoarthritis associated with obesity\u003c\/li\u003e\n\u003cli data-end=\"1344\" data-start=\"1312\" data-section-id=\"13nbu8m\"\u003eCardiometabolic risk reduction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1563\" data-start=\"1346\"\u003eRetatrutide differs from tirzepatide because it also activates the \u003cstrong data-end=\"1434\" data-start=\"1413\"\u003eglucagon receptor\u003c\/strong\u003e, which may increase energy expenditure and fat oxidation in addition to reducing appetite. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 data-end=\"1585\" data-start=\"1565\" data-section-id=\"58r2q1\"\u003eWhy combine them?\u003c\/h2\u003e\n\u003cp data-end=\"1696\" data-start=\"1642\"\u003ePotential rationale discussed in research communities:\u003c\/p\u003e\n\u003cul data-end=\"1940\" data-start=\"1697\"\u003e\n\u003cli data-end=\"1753\" data-start=\"1697\" data-section-id=\"1kdigbs\"\u003eTirzepatide may provide stronger appetite suppression.\u003c\/li\u003e\n\u003cli data-end=\"1878\" data-start=\"1754\" data-section-id=\"su24s1\"\u003eRetatrutide may contribute additional fat oxidation and increased energy expenditure through glucagon receptor activation.\u003c\/li\u003e\n\u003cli data-end=\"1940\" data-start=\"1879\" data-section-id=\"m590s4\"\u003eTogether, some speculate they could complement one another.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"2422\" data-start=\"2363\" data-section-id=\"1r7kb3d\"\u003eWhat is it commonly stacked with (research discussions)?\u003c\/h2\u003e\n\u003cp data-end=\"2641\" data-start=\"2424\"\u003eOutside formal clinical trials, research vendors and online communities commonly discuss pairing these peptides with compounds that target different biological pathways rather than adding another overlapping incretin.\u003c\/p\u003e\n\u003cp data-end=\"2667\" data-start=\"2643\"\u003eCommon examples include:\u003c\/p\u003e\n\u003cul data-end=\"3264\" data-start=\"2668\"\u003e\n\u003cli data-end=\"2726\" data-start=\"2668\" data-section-id=\"37eb8\"\u003e\n\u003cstrong data-end=\"2685\" data-start=\"2670\"\u003eTesamorelin\u003c\/strong\u003e – researched for visceral fat reduction.\u003c\/li\u003e\n\u003cli data-end=\"2787\" data-start=\"2727\" data-section-id=\"iz4khi\"\u003e\n\u003cstrong data-end=\"2741\" data-start=\"2729\"\u003eAOD-9604\u003c\/strong\u003e – investigated for effects on fat metabolism.\u003c\/li\u003e\n\u003cli data-end=\"2864\" data-start=\"2788\" data-section-id=\"cfo197\"\u003e\n\u003cstrong data-end=\"2800\" data-start=\"2790\"\u003eMOTS-c\u003c\/strong\u003e – studied for mitochondrial metabolism and insulin sensitivity.\u003c\/li\u003e\n\u003cli data-end=\"2984\" data-start=\"2865\" data-section-id=\"1pqvfbd\"\u003e\n\u003cstrong data-end=\"2877\" data-start=\"2867\"\u003eLIPO-C\u003c\/strong\u003e – commonly included in weight-management research protocols, although evidence for weight loss is limited.\u003c\/li\u003e\n\u003cli data-end=\"3083\" data-start=\"2985\" data-section-id=\"1rdxpx3\"\u003e\n\u003cstrong data-end=\"2998\" data-start=\"2987\"\u003eBPC-157\u003c\/strong\u003e – sometimes discussed for recovery or gastrointestinal support in research settings.\u003c\/li\u003e\n\u003cli data-end=\"3264\" data-start=\"3084\" data-section-id=\"11szx0k\"\u003e\n\u003cstrong data-end=\"3102\" data-start=\"3086\"\u003eCagrilintide\u003c\/strong\u003e – an amylin analog investigated alongside GLP-1 therapies because it works through a different appetite-regulation pathway. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"3321\" data-start=\"3266\" data-section-id=\"mw4487\"\u003ePotential advantages (based on individual compounds)\u003c\/h2\u003e\n\u003cp data-end=\"3395\" data-start=\"3323\"\u003eResearchers are interested in whether the combination could potentially:\u003c\/p\u003e\n\u003cul data-end=\"3591\" data-start=\"3396\"\u003e\n\u003cli data-end=\"3439\" data-start=\"3396\" data-section-id=\"1ks6wmf\"\u003eProduce substantial body weight reduction\u003c\/li\u003e\n\u003cli data-end=\"3469\" data-start=\"3440\" data-section-id=\"h6h4ut\"\u003eImprove insulin sensitivity\u003c\/li\u003e\n\u003cli data-end=\"3490\" data-start=\"3470\" data-section-id=\"1m64o7q\"\u003eReduce food intake\u003c\/li\u003e\n\u003cli data-end=\"3509\" data-start=\"3491\" data-section-id=\"hk6l57\"\u003eIncrease satiety\u003c\/li\u003e\n\u003cli data-end=\"3557\" data-start=\"3510\" data-section-id=\"17u5amk\"\u003eIncrease fat oxidation and energy expenditure\u003c\/li\u003e\n\u003cli data-end=\"3591\" data-start=\"3558\" data-section-id=\"53ybwn\"\u003eImprove cardiometabolic markers\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Frontline Peptides","offers":[{"title":"Default Title","offer_id":50604501532895,"sku":null,"price":220.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0807\/0810\/8511\/files\/ChatGPTImageJul25_2026_09_24_35PM.png?v=1785029111","url":"https:\/\/frontlinepeptides.net\/products\/tirzepatide-40-mg-retatrutide-20-mg","provider":"Frontline Peptides","version":"1.0","type":"link"}